JamesFChmielMD

Clinical Trials

• Assessment of Inflammatory Mediators (AIM) Start of enrollment: 2004 Aug 01

  Completed

  Not Applicable

• Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations Start of enrollment: 2006 Sep 01

  Completed

• Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma Start of enrollment: 2011 Apr 01

  Completed

  Phase 3

• Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids. Start of enrollment: 2011 Mar 01

  Completed

  Phase 3

• Effect of Sulforaphane in Broccoli Sprouts on Nrf2 Activation Start of enrollment: 2011 Apr 01

  Completed

  Not Applicable

• Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study) Start of enrollment: 2011 Oct 01

  Completed

  Phase 3

• Severe Asthma Research Program Start of enrollment: 2012 Oct 01

  Active, not recruiting

• Airway Redox and Gender Determinants in Severe Asthma Start of enrollment: 2012 Dec 01

  Active, not recruiting

• IL-17 Neutrophils in CF Lung Inflammation Start of enrollment: 2014 Feb 01

  Completed

• OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis Start of enrollment: 2014 Jun 01

  Completed

  Phase 3

• Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation Start of enrollment: 2015 Nov 01

  Completed

  Phase 2

• Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF) Start of enrollment: 2016 Oct 21

  Completed

  Phase 4

• Pulmonary Vascular Disease in CF Start of enrollment: 2020 Jul 29

  Recruiting

• Join now to see all